CentralCharts: Supercharge your portfolio with groundbreaking tools.

NORTHAMPTON, MA / ACCESSWIRE / May 13, 2024 / Join us this Wednesday, May 15 @12pm ET / 9am PT Register now for our first live workshop on how to craft an Impact Communications game plan! On Wed, May 15, at 12pm ET / 9am PT we'll use a real-life case study to lead a collaborative discussion about: What to avoid when seeking to stand up new internal initiatives within our organizations Lessons you've learned from taking bold action at your company Best practices for Impact Communications Lauren...

CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER PR Newswire SAN DIEGO, May 13, 2024 SAN DIEGO , May 13, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced that it has consummated its purchase of Elevated Softgels, LLC ("Elevated Softgels"), a...

ROSEN, A LONGSTANDING LAW FIRM, Encourages Harbor Diversified, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - HRBR PR Newswire NEW YORK, May 13, 2024 NEW YORK , May 13, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Harbor Diversified, Inc. (OTC: HRBR) between May 10, 2022 and March...

Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy PR Newswire PALO ALTO, Calif., May 13, 2024 PALO ALTO, Calif. , May 13, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that the first patients with diabetic retinopathy (DR) have been...

TORONTO, May 13, 2024 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (the “Corporation” or “Dundee”) today announced its financial results for the three months ended March 31, 2024. All currency amounts in this press release are in Canadian dollars, except as otherwise indicated. FIRST QUARTER 2024 RESULTS Reported net income from portfolio investments for the first quarter of 2024 of $12.6 million (2023 – loss of $7.5 million). The key driver of performance during the quarter was...

Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies PR Newswire DURHAM, N.C. and BEIJING, May 13, 2024 DURHAM, N.C. and BEIJING, May 13, 2024 /PRNewswire/ -- Brii Biosciences Limited (" Brii Bio " or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need, today announced that the Center...

GOLD ROYALTY REPORTS FIRST QUARTER 2024 RESULTS; RECORD REVENUE DRIVES POSITIVE OPERATING CASH FLOW PR Newswire VANCOUVER, BC, May 13, 2024 VANCOUVER, BC , May 13, 2024 /PRNewswire/ - Gold Royalty Corp. (" Gold Royalty " or the " Company ") (NYSE American: GROY) is pleased to announce the filing of its operating and financial results for the three months ended March 31, 2024 . All amounts are expressed in U.S. dollars unless otherwise noted. David Garofalo , Chairman and CEO of Gold Royalty,...